Incidence of cardiac toxicities in patients with advanced non-small cell lung cancer treated with osimertinib: A combined analysis of two phase III randomized controlled trials
2018 ◽
Vol 29
◽
pp. viii500
◽
K.Z. Thein
◽
S. Swarup
◽
S. Ball
◽
M. Quirch
◽
Y. Vorakunthada
◽
...
Qiangyun Liu
◽
Zige Fang
◽
Miaowen Liu
◽
Ruoxin Xu
◽
Fengming Yi
◽
...
2011 ◽
Vol 51
(2)
◽
pp. 151-156
◽
Chao Cao
◽
Jianmiao Wang
◽
Hansvin Bunjhoo
◽
Yongjian Xu
◽
Huijuan Fang
Xuan He
◽
Yuanming Li
◽
Ji Wang
2019 ◽
Vol 10
(4)
◽
pp. 885-892
Chi Wang
◽
Yun Li
◽
Li Ke
◽
Lejie Cao
◽
Pingsheng Fan
◽
...
2020 ◽
Vol 126
(22)
◽
pp. 4867-4877
Hossein Borghaei
◽
Corey J. Langer
◽
Luis Paz‐Ares
◽
Delvys Rodríguez‐Abreu
◽
Balazs Halmos
◽
...
2012 ◽
Vol 4
(5)
◽
pp. 849-858
◽
JIAN ZHANG
◽
WEIQING ZHANG
◽
SHAOHONG HUANG
◽
HUI LI
◽
YUN LI
◽
...
2013 ◽
Vol 2
(1)
◽
pp. 146-150
◽
GUODONG SHEN
◽
GENG BIAN
◽
HAIYING YU
◽
MIN GAO
◽
DONGMEI KANG
◽
...
2011 ◽
Vol 189
(3)
◽
pp. 193-198
◽
Ezzeldin M. Ibrahim
◽
Khaled M. Abouelkhair
◽
Osama A. Al-Masri
◽
Najeeb C. Chaudry
◽
Ghieth A. Kazkaz
Han Yang
◽
Xi-Xi Lai
◽
Ren-Ai Xu
◽
Yu-Ping Li
2014 ◽
Vol 15
(14)
◽
pp. 5691-5696
◽
Wei-Lan Wang
◽
Zhi-Hui Tang
◽
Ting-Ting Xie
◽
Bing-Kun Xiao
◽
Xin-Yu Zhang
◽
...
Close
Export Citation Format
Close
Share Document
Close